Key result
Hypersensitivity myocarditis was found in 2.8% of explanted hearts, often associated with dobutamine use, but did not significantly affect post-transplant survival compared to other causes of heart failure.
Why the study?
Does the presence of hypersensitivity myocarditis (HSM) affect post-transplant survival in patients undergoing heart transplantation for advanced heart failure?
Population
761 consecutive patients undergoing de novo heart transplantation for advanced heart failure at a single…
Comparison
Presence of hypersensitivity myocarditis with… vs Patients transplanted for active myocarditis or…
Design
Cohort
Authors
Loading...
Incidental HSM should not alter post-transplant management; leaves open dobutamine's causal role in advanced HF.
Observational (n=761)
No
Does the presence of hypersensitivity myocarditis (HSM) affect post-transplant survival in patients undergoing heart transplantation for advanced heart failure?
Incidental finding of hypersensitivity myocarditis in explanted hearts of advanced heart failure patients is associated with multiple pre-transplant medications (especially dobutamine) but does not adversely affect post-transplant survival.
Yoshizawa et al. (2013) conducted an observational in Advanced heart failure (n=761). Hypersensitivity myocarditis (eosinophilic infiltration) vs. Active myocarditis or other causes of heart failure was evaluated on Post-transplant survival. Hypersensitivity myocarditis was found in 2.8% of explanted hearts, often associated with dobutamine use, but did not significantly affect post-transplant survival compared to other causes of heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: